P53 Status Influences the Anti-proliferative Effect Induced by IFITM1 Inhibition in Estrogen Receptor-positive Breast Cancer Cells
Cancer Genomics - Proteomics · 2024
DOI: 10.21873/cgp.20468 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2024. Verfasst von DER Sheng Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Tumor Suppressor Protein p53, Cell Proliferation, Antigens, Differentiation. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Clinical Research Laboratory, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea dydtjr97@catholic.ac.kr.
- Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; woncomet@catholic.ac.kr.
Zitieren
APA
Sun, S., Yoon, J. S., Kim, Y. S., & Won, H. S. (2024). P53 Status Influences the Anti-proliferative Effect Induced by IFITM1 Inhibition in Estrogen Receptor-positive Breast Cancer Cells. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20468
Vancouver
Sun S, Yoon JS, Kim YS, Won HS. P53 Status Influences the Anti-proliferative Effect Induced by IFITM1 Inhibition in Estrogen Receptor-positive Breast Cancer Cells. Cancer Genomics - Proteomics. 2024. doi:10.21873/cgp.20468
BibTeX
@article{Sun2024,
author = {Sun, DER Sheng and Yoon, Jung-Sook and Kim, Yong-Seok and Won, Hye Sung},
title = {P53 Status Influences the Anti-proliferative Effect Induced by IFITM1 Inhibition in Estrogen Receptor-positive Breast Cancer Cells},
journal = {Cancer Genomics - Proteomics},
year = {2024},
doi = {10.21873/cgp.20468}
}
EUVIMED